Shi L, Fatemi SH, Sidwell RW, Patterson PH
Read on for more on what that means, how clinical trials work, who may qualify, and what to do if a trial isnt an option for you (spoiler alert: you have options!)
After repeated administration, rats in the short-access paradigm exhibited lower daily and cumulative METH intake than saline controls, with this effect becoming apparent on the second day of treatment and continuing throughout the study, while LIR did not affect METH-taking behavior in the extended-access paradigm
More impressively, in the chronic unpredictable stress model (a more severe, clinically relevant paradigm), BPC-157 maintained effectiveness at both 4-day and 6-day assessments while imipramine 30 mg daily only became effective after prolonged treatment
Then what's also built into it is this safety switch where you don't really get the low hypoglycemia that you can get with insulin